Edition:
United Kingdom

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

104.18USD
16 Nov 2018
Change (% chg)

$-0.05 (-0.05%)
Prev Close
$104.23
Open
$102.72
Day's High
$105.38
Day's Low
$102.38
Volume
237,443
Avg. Vol
182,886
52-wk High
$116.61
52-wk Low
$82.86

Select another date:

Sat, Oct 6 2018

USITC to investigate Resmed for alleged patent infringement

WASHINGTON The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems.

USITC to investigate Resmed for alleged patent infringement

WASHINGTON, Oct 5 The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems.

NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

UPDATE 1-NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Sept 11 Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

NZ's Fisher & Paykel Healthcare files patent infringement complaint against ResMed

Sept 11 Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint in the United States against ResMed .

UPDATE 1-NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs

Sept 3 New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

NZ's Fisher & Paykel Healthcare cuts FY guidance on higher expected legal costs

Sept 3 New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

BRIEF-Infoscan Signs LoI With ResMed Polska

* REPORTED ON WEDNESDAY IT HAS SIGNED LETTER OF INTENT (LOI) WITH RESMED POLSKA ON COOPERATION

Select another date: